Ctw
CTW Nasdaq Services-Computer Processing & Data Preparation Financials FY2023–FY2026
What Ctw does
No business description yet.
- Legal name
- CTW
- Fiscal year ends
- July 31, 2026
- Latest annual report
- 20-F · Oct 16, 2026
- Accession · CIK
- 0001213900-26-110271
0002047148
Revenue and margins
Ctw had $82.5M of revenue in fiscal 2026, down 8.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$3.6M in fiscal 2026, −4.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ctw returned — to shareholders in fiscal 2026. The diluted share count rose 4.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Ctw can carry it.
| Fiscal year end | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Cash and short-term investments | $14.6M | $14.5M | $12.2M | $14.4M |
| Current ratio | — | 1.5x | 2.1x | 1.6x |
| Quick ratio | — | 1.5x | 2.1x | 1.6x |
| Total assets | — | $43.9M | $46.5M | $54.8M |
| Total liabilities | — | $20.1M | $18.9M | $20.7M |
| Shareholders' equity | $18.9M | $23.8M | $27.6M | $34.1M |
| Net debt (− = net cash) | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✕ |
| Return on assets rose | — | — | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✕ | ✓ |
| Debt fell relative to assets | — | — | — | — |
| Current ratio rose | — | — | ✓ | ✕ |
| Share count didn't rise | — | ✓ | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ | ✕ |
| Revenue rose relative to assets | — | — | ✓ | ✕ |
| F-score | — / 3 | — / 5 | 5 / 8 | 1 / 8 |
| Accruals ratio | — | 10.0% | 8.2% | −1.9% |
| Altman Z'' | — | 5.26 | 4.98 | 3.37 |
4 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $62.9M | $68.4M | $90.4M | $82.5M |
| Gross profit | $45.9M | $52.2M | $68.3M | $54.0M |
| Research and development | $2.9M | $1.0M | $5.5M | $3.8M |
| Operating income | $5.6M | $6.7M | −$1.1M | −$7.3M |
| Pretax income | $5.2M | $8.2M | $4.4M | −$5.8M |
| Income tax | $1.8M | $2.2M | $0.6M | −$1.7M |
| Net income | $3.4M | $6.0M | $3.8M | −$4.1M |
| Diluted EPS | $0.06 | $0.10 | $0.06 | −$0.07 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||
| Cash from operations | $2.6M | $1.6M | $0.1M | −$3.2M |
| Capital expenditure | $0.1M | $0.7M | $0.6M | $0.4M |
| Free cash flow | $2.4M | $0.9M | −$0.5M | −$3.6M |
| Depreciation and amortization | $0.8M | $2.1M | $2.7M | $2.6M |
| Stock-based compensation | — | — | — | $2.0M |
| Balance sheet | ||||
| Cash and short-term investments | $14.6M | $14.5M | $12.2M | $14.4M |
| Current assets | — | $18.2M | $18.1M | $20.5M |
| Current liabilities | — | $12.0M | $8.4M | $13.1M |
| Property and equipment, net | — | $0.9M | $1.1M | $1.1M |
| Intangible assets | — | — | — | $3.5M |
| Total assets | — | $43.9M | $46.5M | $54.8M |
| Total liabilities | — | $20.1M | $18.9M | $20.7M |
| Shareholders' equity | $18.9M | $23.8M | $27.6M | $34.1M |
| Margins | ||||
| Gross margin | 72.9% | 76.3% | 75.6% | 65.5% |
| Operating margin | 8.9% | 9.7% | −1.2% | −8.9% |
| EBITDA margin | 10.1% | 12.7% | 1.8% | −5.8% |
| Net margin | 5.4% | 8.7% | 4.2% | −5.0% |
| FCF margin | 3.9% | 1.3% | −0.5% | −4.3% |
| Returns | ||||
| Return on capital employed | — | 20.8% | −2.8% | −17.5% |
| Return on equity | 18.0% | 28.0% | 14.9% | −13.4% |
| Return on assets | — | 13.6% | 8.5% | −8.2% |
| Return on tangible equity | 18.0% | 25.1% | 13.8% | −13.5% |
| Growth | ||||
| Revenue growth | — | 8.7% | 32.1% | −8.7% |
| Net income growth | — | 75.9% | −36.0% | −207.9% |
| EPS growth | — | 66.7% | −40.0% | −216.7% |
| FCF growth | — | −63.8% | −154.0% | — |
| Share count change | — | 0.0% | 0.0% | 4.0% |
| Financial health | ||||
| Current ratio | — | 1.5x | 2.1x | 1.6x |
| Quick ratio | — | 1.5x | 2.1x | 1.6x |
| Capital allocation | ||||
| Capex / revenue | 0.2% | 1.0% | 0.6% | 0.5% |
| Stock comp / revenue | — | — | — | 2.4% |
| Quality scores | ||||
| Piotroski F-score | — | — | 5.0 | 1.0 |
| Altman Z'' | — | 5.3 | 5.0 | 3.4 |
| Accruals ratio | — | 10.0% | 8.2% | −1.9% |
Source: SEC EDGAR XBRL filings (CIK 0002047148). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.